A 45-year-old male construction worker with a confirmed deep vein thrombosis (DVT) and mild pulmonary embolism (PE) is initiated on low molecular weight heparin therapy. Which nursing intervention is most important to prioritize to prevent further complications?

B) Educate the patient on the signs and symptoms of bleeding to report immediately.

A) Encourage the patient to increase fluid intake to maintain hydration.

B) Educate the patient on the signs and symptoms of bleeding to report immediately.

C) Advise the patient to perform leg exercises to improve venous return.

D) Monitor the patient's blood glucose levels closely for potential hyperglycemia.

A 45-year-old male construction worker has been diagnosed with a deep vein thrombosis (DVT) and a mild pulmonary embolism (PE). He is currently receiving anticoagulation therapy with low molecular weight heparin. Which nursing intervention is most important to prioritize in his care plan to prevent further complications?

B) Monitor for signs of increased bruising or bleeding.

A) Encourage the patient to perform ankle pumps and leg exercises regularly.

B) Monitor for signs of increased bruising or bleeding.

C) Educate the patient on the importance of a low-sodium diet.

D) Recommend complete bed rest until symptoms resolve.

A patient with pulmonary embolism is experiencing worsening symptoms despite being on anticoagulation therapy. Which nursing intervention is most appropriate to prioritize for this patient?

C) Collaborate with the healthcare team to discuss potential transition to a direct oral anticoagulant (DOAC)

A) Increase the frequency of vital sign monitoring to every hour

B) Educate the patient on the importance of adhering to prescribed dietary restrictions

C) Collaborate with the healthcare team to discuss potential transition to a direct oral anticoagulant (DOAC)

D) Initiate an exercise program to improve patient mobility and lung capacity

A patient with a known pulmonary embolism is on anticoagulation therapy but presents with worsening shortness of breath and diminished breath sounds in the right lower lung field. Repeat imaging shows additional emboli, and laboratory tests indicate elevated D-dimer levels with therapeutic PT/INR. What is the most appropriate initial nursing action?

B) Notify the healthcare provider about the patient's symptoms and lab results

A) Increase the dose of the current anticoagulant

B) Notify the healthcare provider about the patient's symptoms and lab results

C) Educate the patient on lifestyle modifications to prevent further emboli

D) Administer supplemental oxygen to maintain adequate oxygen saturation

A patient with a history of deep vein thrombosis and pulmonary embolism has been transitioned from warfarin to a direct oral anticoagulant (DOAC) due to continued thromboembolic risk. The patient's respiratory symptoms have improved, and vital signs are stable. What is the most important nursing intervention to ensure the effectiveness of the new anticoagulation therapy?

A) Educate the patient on the importance of adhering to the prescribed DOAC regimen.

B) Monitor the patient's blood pressure and heart rate daily.

C) Schedule regular D-dimer tests to assess clotting activity.

D) Encourage the patient to increase fluid intake to promote circulation.

A patient with a history of deep vein thrombosis and pulmonary embolism is transitioned from warfarin to a direct oral anticoagulant (DOAC) due to continued risk of thromboembolic events. The nurse is educating the patient about the new medication. Which statement by the patient indicates a need for further teaching?

B) 'I need to have my INR checked regularly while on this medication.'

A) 'I should take this medication at the same time every day to maintain consistent blood levels.'

B) 'I need to have my INR checked regularly while on this medication.'

C) 'I should report any unusual bleeding or bruising to my healthcare provider immediately.'

D) 'I should avoid taking NSAIDs unless approved by my healthcare provider.'

A patient on a new DOAC anticoagulation regimen presents with signs of thrombus extension in the right popliteal vein. What is the most appropriate nursing intervention to prioritize at this time?

A) Educate the patient on the importance of adhering to prescribed anticoagulation therapy

B) Encourage the patient to increase physical activity to promote venous return

C) Monitor for signs of bleeding due to potential over-anticoagulation

D) Initiate a rapid bolus of intravenous fluids to improve circulation

A patient on a direct oral anticoagulant (DOAC) for deep vein thrombosis (DVT) presents with new symptoms of right calf pain, swelling, increased warmth, erythema, and a positive Homan's sign. A Doppler ultrasound confirms thrombus extension in the right popliteal vein. What is the nurse's priority action in managing this patient?

B) Contact the healthcare provider to discuss possible adjustment or addition of anticoagulation therapy.

A) Educate the patient on the importance of medication adherence and lifestyle modifications.

B) Contact the healthcare provider to discuss possible adjustment or addition of anticoagulation therapy.

C) Instruct the patient to apply warm compresses to the affected leg to alleviate discomfort.

D) Recommend the patient increases fluid intake and leg elevation to reduce swelling.

A patient with a recent diagnosis of deep vein thrombosis (DVT) is reporting mild dyspnea and a persistent cough. Vital signs show a slight increase in respiratory rate and a decrease in oxygen saturation. A CTPA confirms the presence of small bilateral pulmonary emboli. What is the most appropriate initial nursing intervention?

C) Administer supplemental oxygen to maintain adequate oxygenation

A) Place the patient in a high Fowler's position to facilitate breathing

B) Initiate rapid bolus of IV fluids to improve circulation

C) Administer supplemental oxygen to maintain adequate oxygenation

D) Prepare the patient for immediate thrombolytic therapy

A patient with a known deep vein thrombosis has developed small, bilateral pulmonary emboli despite being on anticoagulation therapy. The clinical team is considering additional interventions. Based on the patient's current condition and the potential need for further intervention, which nursing action is most appropriate?

C) Prepare the patient for the insertion of an inferior vena cava (IVC) filter.

A) Monitor the patient's respiratory status every 4 hours and report any significant changes.

B) Educate the patient on the signs and symptoms of bleeding as a side effect of increased anticoagulation therapy.

C) Prepare the patient for the insertion of an inferior vena cava (IVC) filter.

D) Encourage the patient to perform early ambulation to prevent further thrombus formation.

DVT - Nursing Case Study

Pathophysiology

• Primary mechanism: Venous stasis occurs when blood flow slows down in the veins, usually due to immobility or prolonged bed rest, leading to increased risk of clot formation as blood pools and coagulation factors accumulate.

• Secondary mechanism: Endothelial damage to the vessel wall, often caused by trauma or inflammation, exposes subendothelial tissue and initiates the clotting cascade, promoting thrombus formation.

• Key complication: Pulmonary embolism can occur if part of the thrombus dislodges and travels to the lungs, potentially causing life-threatening respiratory distress and requiring immediate medical intervention.

Patient Profile

Demographics:

45-year-old male, construction worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes

• Current medications: Lisinopril, Metformin, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Pain and swelling in the left leg

• Key symptoms: Warmth and redness in left calf, mild shortness of breath, fatigue

• Vital signs: Blood pressure 150/95 mmHg, heart rate 105 bpm, respiratory rate 22 breaths per minute, temperature 99.1°F

Section 1

As the clinical team proceeds with the initial assessment of the 45-year-old male construction worker, further examination of his left leg confirms significant edema, extending from the ankle to the mid-thigh. Doppler ultrasound is promptly ordered, revealing the presence of a deep vein thrombosis (DVT) in the left popliteal vein. Given the mild shortness of breath reported by the patient, a CT pulmonary angiogram is also performed to assess for potential pulmonary embolism (PE). The imaging study indicates the presence of small emboli in the segmental arteries of the right lower lobe, confirming a mild PE.

Lab results reveal elevated D-dimer levels, indicative of recent clot formation, and a slight increase in white blood cell count suggestive of an inflammatory response. Arterial blood gas analysis shows mild respiratory alkalosis, with a pH of 7.46, a PaCO2 of 32 mmHg, and a PaO2 of 78 mmHg. These findings align with hyperventilation due to PE-related hypoxia. The patient's blood glucose level is noted to be 182 mg/dL, slightly above his typical range, likely due to stress-induced hyperglycemia.

In light of these findings, the care team initiates anticoagulation therapy with low molecular weight heparin to prevent further clot formation and reduce the risk of additional emboli. The patient is monitored closely for any signs of worsening respiratory status or bleeding complications. The clinical team discusses with the patient the importance of adherence to medication, regular monitoring of blood pressure and glucose levels, and lifestyle modifications to mitigate risk factors. This plan aims to stabilize his current condition and prevent further complications, setting the stage for the next phase of his treatment and recovery.

Section 2

A few days into the treatment, the patient begins experiencing worsening shortness of breath and a persistent cough. Vital signs reveal a respiratory rate of 24 breaths per minute, oxygen saturation dropping to 90% on room air, and a mild tachycardia with a heart rate of 105 beats per minute. The clinical team promptly reassesses the patient, noting increased respiratory effort and diminished breath sounds on the right lower lung field upon auscultation. Concerned about potential progression of the pulmonary embolism, a repeat CT pulmonary angiogram is conducted, revealing the presence of additional small emboli in the right middle lobe and increased involvement in the lower lobe.

Simultaneously, laboratory tests are repeated, showing further elevation in D-dimer levels and a slight drop in hemoglobin to 13 g/dL, raising concerns about potential bleeding due to anticoagulation therapy. The patient's PT/INR levels are within therapeutic range, suggesting effective anticoagulation. However, the persistence of embolic events indicates a need to reassess treatment efficacy and consider alternative or adjunctive therapies.

The clinical team discusses with the patient the need for potential adjustments in his anticoagulation regimen, including the possibility of transitioning to a direct oral anticoagulant (DOAC) for better management of his condition. Emphasis is placed on the importance of rigorous follow-up and monitoring, including regular blood tests and imaging studies, to ensure therapeutic effectiveness and minimize the risk of further complications. The team also revisits lifestyle modifications, stress management strategies, and the need for vigilant monitoring of glucose levels to address stress-induced hyperglycemia, aiming to optimize the patient's recovery trajectory.

Section 3

Following the reassessment and discussions with the patient, the clinical team decides to transition the patient to a direct oral anticoagulant (DOAC) to address the continued risk of thromboembolic events despite therapeutic anticoagulation with warfarin. This decision is made after careful consideration of the patient's current clinical status, lab results, and the potential for better management of his deep vein thrombosis and pulmonary embolism. The patient is educated about the new medication, including the importance of adherence, potential side effects, and the need for regular follow-up appointments to monitor his response to the treatment.

Over the next few days, the patient begins to show signs of stabilization. His respiratory symptoms start to improve, with his oxygen saturation rising to 94% on room air and his respiratory rate decreasing to 20 breaths per minute. The patient reports feeling less short of breath, and his cough becomes less frequent. These positive changes, along with stable vital signs—heart rate of 98 beats per minute and blood pressure of 120/78 mmHg—indicate a favorable response to the adjusted anticoagulation therapy. The team notes an improvement in the patient's overall respiratory effort and clearer breath sounds on auscultation of the right lung.

However, the clinical team remains vigilant, recognizing the potential for further complications given the patient's recent history. A repeat D-dimer test shows a slight decrease, indicating a reduction in clotting activity, while hemoglobin levels stabilize at 13 g/dL, alleviating immediate concerns about bleeding risks. These findings suggest that the treatment adjustments are effective, but the patient continues to be monitored closely. The team also reiterates the importance of lifestyle modifications, emphasizing the management of stress and monitoring of glucose levels to prevent future complications. Regular follow-up appointments are scheduled to ensure ongoing assessment and timely intervention should any new issues arise, keeping the patient's recovery on a positive trajectory.

Section 4

A few days into the new anticoagulation regimen with the DOAC, the patient begins to experience new symptoms that prompt further investigation by the clinical team. The patient reports a sudden onset of right calf pain and swelling, which is more pronounced than before. Upon physical examination, the affected leg shows increased warmth, erythema, and tenderness, with a positive Homan's sign suggesting a potential recurrence or extension of the thrombus in the deep venous system. Vital signs remain stable overall, with a heart rate of 102 beats per minute and blood pressure at 118/76 mmHg, but the new localized symptoms raise concern.

In response to these developments, the clinical team orders a Doppler ultrasound of the lower extremities to evaluate the status of the venous circulation. The ultrasound reveals an extension of the existing thrombus in the right popliteal vein, indicating that while the initial anticoagulation adjustment appeared effective, the thrombus's progression necessitates further intervention. The lab work shows an elevated D-dimer level once again, signaling increased fibrinolytic activity. The patient's renal function remains stable, with a creatinine level of 1.1 mg/dL, allowing for continued use of the prescribed DOAC without adjustment at this time.

Given these findings, the clinical team deliberates on the next steps, considering the possibility of adjunctive therapies or further adjustments to the anticoagulation strategy. They emphasize the need for the patient to maintain strict adherence to medication and lifestyle modifications, including avoiding prolonged immobility and ensuring adequate hydration. The patient is educated on recognizing signs of potential complications, such as increased pain, swelling, or respiratory distress, and advised to seek immediate medical attention if these occur. Regular follow-up and monitoring are reinforced, with plans to reassess the treatment strategy in light of the evolving clinical picture.

Section 5

As the patient's journey continues, the clinical team closely monitors for any changes in status, given the recent extension of the thrombus despite anticoagulation therapy. Over the next 24 hours, the patient begins to report mild dyspnea, especially upon exertion, and a persistent cough. Although these symptoms are subtle, they prompt further investigation due to the potential risk of pulmonary embolism, a known complication of deep vein thrombosis.

Vital signs remain largely stable, but the patient's respiratory rate increases slightly to 22 breaths per minute, and oxygen saturation drops to 92% on room air, indicating a mild respiratory compromise. These findings, combined with the new respiratory symptoms, lead the team to order a computed tomography pulmonary angiography (CTPA) to assess for the presence of embolic events. The CTPA results reveal small, bilateral pulmonary emboli, confirming the suspicion and underscoring the need for an urgent reassessment of the anticoagulation strategy.

In response to these developments, the clinical team discusses the potential benefits of transitioning the patient to a different anticoagulation regimen or considering the addition of a temporary inferior vena cava (IVC) filter to prevent further embolic complications while the current thrombus stabilizes. They emphasize the importance of continuing to monitor the patient's respiratory status closely and adjust interventions as needed. The patient is counseled on the significance of these findings and the need for vigilance in recognizing any worsening symptoms, reinforcing the collaborative approach to managing this complex clinical scenario.